Adolescent obesity carries higher thrombus risk later in life

Men with a history of obesity in their late teens are, in adult life, more at risk of a blood clot (thrombus) in a leg or lung, according to a study from the University of Gothenburg study shows. The risk rises successively and is highest in those who were severely obese in adolescence.

A thrombus in the leg or lung is known as venous thromboembolism (VTE). This is one of our most common cardiovascular diseases. Risk increases with advancing age and, overall, 5-10 percent of the population are affected at some time during their lives. The disease is potentially fatal, but its degree of severity varies.

The current study, published in Journal of Internal Medicine, is based on data on 1,639,838 men who enlisted for military service in Sweden in the years 1969-2005. Their average age on enlistment was just over 18 years. These individuals were followed up using patient and cause-of-death registers.

During the follow-up period, with a median duration of 28 years, a blood clot in the leg or lung was registered among just over 1 percent (n=18,665) of the study participants. A clear association was found between body mass index (BMI) at the time of enlistment and subsequent thrombus risk.

A successive rise in VTE risk was also observed in the group in the middle and the upper part of the normal BMI range (20-25), compared with the lower part of the normal range (18.5-20).

The risk then continued to rise in the two higher BMI groups, those with obesity and severe obesity, to which more than 36,000 of the study participants belonged.

In the group with obesity (BMI 30-35), the relative risk was 2.93 compared with the reference group in the study -- over twice as high. For those with severe obesity, the corresponding relative risk was 4.95, i.e. a nearly fivefold risk for blood clots in the leg or lung during the follow-up period.

Katarina Glise Sandblad is a PhD student at Sahlgrenska Academy, University of Gothenburg, a resident physician specializing in internal medicine at Sahlgrenska University Hospital and the first author of the study.

Up to now, the association between VTE and obesity has been studied mainly in populations where BMI is measured relatively late in life. By then, the study participants may have developed obesity-related diseases, such as certain forms of cancer, that also affect their thrombus risk.

Consequently, there's a danger of underestimating the risk from obesity. As obesity and severe obesity become more prevalent among children and adolescents, it's increasingly important to study the long-term risks involved,"

Dr Katarina Glise Sandblad, PhD Student, Sahlgrenska Academy

Although the current study covers men only, the patterns and associations found are probably similar for women, in the research group's opinion. Heading the group is Annika Rosengren, Professor of Medicine at the University of Gothenburg.

The group has previously conducted studies of obesity and outcomes other than VTE, such as heart attack, stroke, heart failure and cardiomyopathy, where similar patterns in both men and women have been observed.

Source:
Journal reference:

Sandblad, K. G., et al. (2020) Obesity in adolescent men increases the risk of venous thromboembolism in adult life. Journal of Internal Medicine. doi.org/10.1111/joim.13044.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes